Clinical Trials
Several clinical trials are currently actively recruiting participants to evaluate interventions and diagnostic methodologies for conditions such as prostate cancer and racism-related life stress. Operating under unassigned or non-applicable phase designations, these studies are sponsored by federal entities like the VA Office of Research and Development as well as major academic institutions, including the Chinese University of Hong Kong, Northwestern University, and Johns Hopkins University. Together, these research endeavors aim to advance diagnostic precision and stress resilience management.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05422638 | Recruiting | Life Stress|Racism |
VA Office of Research and Development |
2023-01-02 | Not Applicable |
| NCT05295407 | Recruiting | Prostate Cancer |
NorthShore University HealthSystem|Northwestern University|Johns Hopkins University|GoPath Diagnostics |
2021-12-13 | -- |
| NCT05438524 | Recruiting | Prostate Cancer |
Chinese University of Hong Kong |
2021-11-11 | -- |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).